Table 1.
Characteristics | n = 52 |
---|---|
Age (years) | 28 [24–35] (30) |
> 35 years | 16 (30.8%) |
Parity | 2 [1–6] (3) |
Nulliparous | 9 (17.3%) |
Reasons for SARS-CoV-2 testing | |
Reported symptoms | 21 (40.4%) |
Routine screening | 18 (34.7%) |
Presumed exposure to affected individuals | 13 (25.0%) |
Symptomatic | 27 (51.9%) |
Fever | 11 (21.2%) |
Cough | 14 (26.9%) |
Dyspnea | 6 (11.5%) |
Sore throat | 4 (7.7%) |
Gastrointestinal symptoms | 4 (7.7%) |
Loss of taste/smell | 5 (9.6%) |
Platelet count (X 109/L) | 191 [156–240] (197) |
White blood cell count (X 109/L) | 9.8 [8.0–11.8] (10.4) |
Hemoglobin (g/dL) | 12.5 [11.9–13.3] (12.4) |
Abnormal liver enzymes* | 6 (11.5%) |
C-reactive protein (mg/L) | 17.1 [3.0–29.5] (31.3) |
All continuous variables are expressed as medians [interquartile range] (means)
*Aspartate aminotransferase or alanine aminotransferase higher than two-fold the upper limit of normal range (> 35 IU/L)
†Normal range for C-reactive protein < 5 mg/L